Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Bipolarity and inadequate response to antidepressant drugs: clinical and psychopharmacological perspective.

Rybakowski JK.

J Affect Disord. 2012 Jan;136(1-2):e13-e19. doi: 10.1016/j.jad.2011.05.005. Epub 2011 May 31. Review.

PMID:
21621266
2.

Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.

Hantouche EG, Akiskal HS, Lancrenon S, Chatenêt-Duchêne L.

J Affect Disord. 2005 Feb;84(2-3):243-9.

PMID:
15708422
3.

Use of the Hypomania Checklist-32 and the Mood Disorder Questionnaire for detecting bipolarity in 1051 patients with major depressive disorder.

Rybakowski JK, Dudek D, Pawlowski T, Lojko D, Siwek M, Kiejna A.

Eur Psychiatry. 2012 Nov;27(8):577-81. doi: 10.1016/j.eurpsy.2010.12.001. Epub 2011 Feb 11.

PMID:
21316202
4.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
5.

Bipolar II disorder : epidemiology, diagnosis and management.

Benazzi F.

CNS Drugs. 2007;21(9):727-40. Review.

PMID:
17696573
6.

Utilization of Psychopharmacological Treatment Among Patients With Newly Diagnosed Bipolar Disorder From 2001 to 2010.

Chang CM, Wu CS, Huang YW, Chau YL, Tsai HJ.

J Clin Psychopharmacol. 2016 Feb;36(1):32-44. doi: 10.1097/JCP.0000000000000440.

PMID:
26650974
7.

Antidepressant-associated mania or hypomania: a comparison with personality and bipolarity features of bipolar I disorder.

Saatcioglu O, Erim R, Tomruk N, Oral T, Alpay N.

J Affect Disord. 2011 Nov;134(1-3):85-90. doi: 10.1016/j.jad.2011.05.019. Epub 2011 May 31.

PMID:
21632117
8.

Pharmacotherapy of depression and mixed states in bipolar disorder.

Montgomery SA, Schatzberg AF, Guelfi JD, Kasper S, Nemeroff C, Swann A, Zajecka J.

J Affect Disord. 2000 Sep;59 Suppl 1:S39-S56. Review.

PMID:
11121826
9.

The utility of Mood Disorder Questionnaire for the detection of bipolar diathesis in treatment-resistant depression.

Kiejna A, Pawłowski T, Dudek D, Lojko D, Siwek M, Roczeń R, Rybakowski JK.

J Affect Disord. 2010 Aug;124(3):270-4. doi: 10.1016/j.jad.2009.12.003. Epub 2010 Jan 13.

PMID:
20060173
10.

Predictors of efficacy in lithium augmentation for treatment-resistant depression.

Sugawara H, Sakamoto K, Harada T, Ishigooka J.

J Affect Disord. 2010 Sep;125(1-3):165-8. doi: 10.1016/j.jad.2009.12.025. Epub 2010 Jan 20.

PMID:
20089312
11.
12.

Treatment options for acute depression in bipolar disorder.

Bauer M, Ritter P, Grunze H, Pfennig A.

Bipolar Disord. 2012 May;14 Suppl 2:37-50. doi: 10.1111/j.1399-5618.2012.00991.x. Review.

PMID:
22510035
13.

A closer look at treatment resistant depression: is it due to a bipolar diathesis?

Sharma V, Khan M, Smith A.

J Affect Disord. 2005 Feb;84(2-3):251-7.

PMID:
15708423
14.

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.

Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N.

Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. Review.

15.

Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study.

Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Gamma A, Young AH; BRIDGE Study Group.

Arch Gen Psychiatry. 2011 Aug;68(8):791-8. doi: 10.1001/archgenpsychiatry.2011.87.

PMID:
21810644
16.

Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.

Ivković M, Damjanović A, Jovanović A, Cvetić T, Jasović-Gasić M.

Psychiatr Danub. 2009 Jun;21(2):187-93.

17.

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.

Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.

J Clin Psychiatry. 2009 Oct;70(10):1424-31. doi: 10.4088/JCP.08m04772gre.

PMID:
19906346
18.

Treatments for late-life bipolar disorder.

Aziz R, Lorberg B, Tampi RR.

Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. Review.

PMID:
17296540
19.

Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.

Nierenberg AA, Ostacher MJ, Calabrese JR, Ketter TA, Marangell LB, Miklowitz DJ, Miyahara S, Bauer MS, Thase ME, Wisniewski SR, Sachs GS.

Am J Psychiatry. 2006 Feb;163(2):210-6.

PMID:
16449473
20.

Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II).

Akiskal HS, Hantouche EG, Allilaire JF, Sechter D, Bourgeois ML, Azorin JM, Chatenêt-Duchêne L, Lancrenon S.

J Affect Disord. 2003 Jan;73(1-2):65-74.

PMID:
12507739

Supplemental Content

Support Center